(Q41718118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

Middle East respiratory syndrome coronavirus

20 February 2020

main subject

0 references

0 references

1 reference

1 reference

Middle East respiratory syndrome

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Kamran Baig

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

9

Ziad A Memish

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Mustafa M Saad

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Abdelkarim Bahloul

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Mohammed Abdul-Matin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Amal Y Alaidaroos

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Ghaleb A Almakhlafi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Mohammed M Albarrak

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Ali M Albarrak

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

English

0 references

publication date

29 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

1090-1095

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25278221%20AND%20SRC:MED&resulttype=core&format=json

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

20 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Hospital outbreak of Middle East respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

The severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

SARS: systematic review of treatment effects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Applying lessons from SARS to a newly identified coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Common Adverse Events Associated with the Use of Ribavirin for Severe Acute Respiratory Syndrome in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021

Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2814%2970920-X

7 January 2021